TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The cancer-prone and premature aging disease Werner syndrome is due to loss of WRN gene function. Cells lacking WRN demonstrate genomic instability, including telomeric abnormalities and undergo premature senescence, suggesting defects in telomere metabolism. This notion is strongly supported by our finding of physical and functional interactions between WRN and TRF2, a telomeric repeat binding factor essential for proper telomeric structure. TRF2 binds to DNA substrates containing telomeric repeats and facilitates their degradation specifically by WRN exonuclease activity. WRN and TRF2 also interact directly in the absence of DNA. These results suggest that TRF2 recruits WRN for accurate processing of telomeric structures in vivo. Thus, our findings link problems in telomere maintenance to both carcinogenesis and specific features of aging.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“WRN also interacts with the telomeric protein TRF2 and can unwind and degrade telomeric D loop structures.”
From DNA Repair, Genome Stability, and Aging (2005) · cites this paper as Machwe et al., 2004
In the citing paper
“These observations suggest that WRN may play a role in providing telomeric access to other factors involved in telomere maintenance (Machwe et al., 2004; Opresko et al., 2004; Orren et al., 2002”
From DNA Repair, Genome Stability, and Aging (2005) · cites this paper as Machwe et al., 2004
Citations
Cites
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 2×
“TRF2 may accomplish this essential telomere protection function by formation and stabilization of looped telomeric structures known as T-loops (Griffith et al., 1999).”
BackgroundHemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219 · cited 1×
“Notably, a single shortened (or unprotected) telomere is sufficient to elicit the latter responses (Hemann et al., 2001).”
BackgroundControl of telomere length by the human telomeric protein TRF1
van Steensel, B., & de Lange, T. (1997) · Nature · doi:10.1038/385740a0 · Cited by 1,219
Protection of mammalian telomeres
de Lange, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205080 · Cited by 942 · cited 2×
“TRF2 specifically protects telomeric ends and thereby suppresses checkpoint activation leading to senescence or apoptosis and prevents end-to-end chromosomal fusions (de Lange, 2002).”
BackgroundHuman telomeres contain two distinct Myb–related proteins, TRF1 and TRF2
Broccoli, D., Smogorzewska, A., Chong, L., & de Lange, T. (1997) · Nature Genetics · doi:10.1038/ng1097-231 · Cited by 926 · cited 1×
“Central to telomere structure and maintenance are TRF1 and TRF2, both of which bind specifically to duplex telomeric repeat sequences (Broccoli et al., 1997), but have discrete functions.”
BackgroundSenescence Induced by Altered Telomere State, Not Telomere Loss
Karlseder, J., Smogorzewska, A., & de Lange, T. (2002) · Science · doi:10.1126/science.1069523 · Cited by 796 · cited 1×
“…with this reasoning, TRF2 overexpression in cells not expressing telomerase leads to overall telomere shortening, including significant G-strand resection, without loss of protection until telomere length is well below the normal length at senescence (Ancelin et al., 2002; Karlseder et al., 2002).”
BackgroundControl of Human Telomere Length by TRF1 and TRF2
Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., & de Lange, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1659-1668.2000 · Cited by 768 · cited 1×
“TRF1 appears to regulate telomeric length by inhibiting telomerase (van Steensel and de Lange, 1997; Smogorzewska et al., 2000; Ancelin et al., 2002).”
BackgroundConnecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561 · cited 2×
“Unprotected telomeres can cause end-to-end chromosomal fusions that, in turn, initiate cycles of breakage and rejoining, possibly accounting for the rampant chromosomal aberrations observed in tumor cells (Maser and Depinho, 2002).”
BackgroundT-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang
M.Stansel, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5532 · Cited by 534 · cited 1×
“The position of this footprint also lends support to the idea that TRF2 may bind proximal to the duplex-overhang junction, as suggested by electron microscope studies (Stansel et al., 2001).”
BackgroundMutator phenotype of Werner syndrome is characterized by extensive deletions.
Fukuchi, K., Martin, G. M., & Monnat, R. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5893 · Cited by 419 · cited 1×
“Cells from WS patients have increased chromosomal aberrations (Fukuchi et al., 1989), telomere abnormalities (Schulz et al., 1996; Tahara et al., 1997), and dramatic premature replicative senescence (Martin et al., 1970).”
BackgroundTelomere-binding Protein TRF2 Binds to and Stimulates the Werner and Bloom Syndrome Helicases
Opresko, P. L., von Kobbe, C., Laine, J.-P., Harrigan, J., Hickson, I. D., & Bohr, V. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205396200 · Cited by 392 · cited 4×
“Another recent study (Opresko et al., 2002) has examined TRF2’s effect on WRN unwinding on much shorter DNA substrates.”
BackgroundResultInfluentialConstantinou, A., Tarsounas, M., Karow, J. K., Brosh, R. M., Bohr, V. A., Hickson, I. D., & West, S. C. (2000) · EMBO reports · doi:10.1093/embo-reports/kvd004 · Cited by 387 · cited 1×
“…be recruited to telomeres by TRF2 to promote or reverse telomeric recombination by the ALT pathway, as WRN colocalizes with TRF2 in ALTutilizing cells (Johnson et al., 2001; Opresko et al., 2002) and can act on specific recombination intermediates (Constantinou et al., 2000; Orren et al., 2002).”
BackgroundTRF1 is a dimer and bends telomeric DNA
Bianchi, A., Smith, S., Chong, L., Elias, P., & de Lange, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1785 · Cited by 358 · cited 1×
“TRF1 and TRF2 were individually overproduced and purified as reported previously (Bianchi et al., 1997), except that TRF2 was eluted in buffer containing 300mm imidazole, 500mm NaCl, 20mm Tris-HCl (pH 8.0), and 5mm b-mercaptoethanol (BME).”
MethodInfluentialTelomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts
Wyllie, F. S., Jones, C. J., Skinner, J. W., Haughton, M. F., Wallis, C., Wynford-Thomas, D., Faragher, R. G. A., & Kipling, D. (2000) · Nature Genetics · doi:10.1038/71630 · Cited by 332 · cited 1×
“Introduction of telomerase immortalizes primary WS cells, linking the premature senescence phenotype to defective telomere length maintenance (Wyllie et al., 2000) and suggesting a role for WRN in telomere metabolism.”
BackgroundFunctional and Physical Interaction between WRN Helicase and Human Replication Protein A
Brosh, R. M., Orren, D. K., Nehlin, J. O., Ravn, P. H., Kenny, M. K., Machwe, A., & Bohr, V. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18341 · Cited by 306 · cited 2×
“Interactions between WRN and several replication factors, including DNA polymerase d, PCNA, and RPA (Brosh et al., 1999; Lebel et al., 1999; KamathLoeb et al., 2000) may deliver WRN to TRF2 and telomeric DNA structures upon replication fork blockage.”
BackgroundSelf-citationJohnson, F. B., Marciniak, R. A., McVey, M., Stewart, S. A., Hahn, W. C., & Guarente, L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.905 · Cited by 269 · cited 2×
“Our observation of a direct interaction between TRF2 and WRN supports recent reports of coimmunoprecipitation and colocalization of these proteins in vivo (Johnson et al., 2001; Opresko et al., 2002).”
BackgroundLebel, M., Spillare, E. A., Harris, C. C., & Leder, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37795 · Cited by 246 · cited 1×
“Interactions between WRN and several replication factors, including DNA polymerase d, PCNA, and RPA (Brosh et al., 1999; Lebel et al., 1999; KamathLoeb et al., 2000) may deliver WRN to TRF2 and telomeric DNA structures upon replication fork blockage.”
BackgroundTelomeres, aging and cancer: In search of a happy ending
Kim, S.-H., Kaminker, P., & Campisi, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205077 · Cited by 230 · cited 2×
“Moreover, telomere erosion and cellular senescence may be involved in cancer etiology and certain aging characteristics (Shay and Wright, 2001; Kim et al., 2002; Maser and Depinho, 2002).”
BackgroundSchulz, V. P., Zakian, V. A., Ogburn, C. E., McKay, J., Jarzebowicz, A. A., Martin, G. M., & Edland, S. D. (1996) · Human Genetics · doi:10.1007/bf02346184 · Cited by 221 · cited 2×
“An inability to disrupt telomeric structures may delay and perhaps truncate replication, explaining the slow S phase and accelerated telomere shortening in WS cells, respectively (Poot et al., 1992; Schulz et al., 1996).”
BackgroundTRF1 binds a bipartite telomeric site with extreme spatial flexibility
Bianchi, A., Stansel, R. M., Fairall, L., Griffith, J. D., Rhodes, D., & de Lange, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5735 · Cited by 217 · cited 10×
“Central to telomere structure and maintenance are TRF1 and TRF2, both of which bind specifically to duplex telomeric repeat sequences (Broccoli et al., 1997), but have discrete functions.”
BackgroundInfluentialImpaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines
PooT, M., Hoehn, H., Rünger, T. M., & Martin, G. M. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90074-i · Cited by 209 · cited 1×
“An inability to disrupt telomeric structures may delay and perhaps truncate replication, explaining the slow S phase and accelerated telomere shortening in WS cells, respectively (Poot et al., 1992; Schulz et al., 1996).”
BackgroundAncelin, K., Brunori, M., Bauwens, S., Koering, C.-E., Brun, C., Ricoul, M., Pommier, J.-P., Sabatier, L., & Gilson, E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3474-3487.2002 · Cited by 205 · cited 2×
“TRF1 appears to regulate telomeric length by inhibiting telomerase (van Steensel and de Lange, 1997; Smogorzewska et al., 2000; Ancelin et al., 2002).”
BackgroundFunctional interaction between the Werner Syndrome protein and DNA polymerase δ
Kamath-Loeb, A. S., Johansson, E., Burgers, P. M. J., & Loeb, L. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4603 · Cited by 186
Telomere maintenance without telomerase
Lundblad, V. (2002) · Oncogene · doi:10.1038/sj.onc.1205079 · Cited by 182 · cited 1×
“T-loop structures may also be intermediates in the recombinational ALT (alternative lengthening of telomeres) pathway (Lundblad, 2002).”
BackgroundDeconstructing cell determination: proneural genes and neuronal identity
Brunet, J.-F., & Ghysen, A. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199904)21:4<313::aid-bies7>3.0.co;2-c · Cited by 135
Telomeres and Telomerase: Implications for Cancer and Aging
Shay, J. W., & Wright, W. E. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0188:tatifc]2.0.co;2 · Cited by 134 · cited 2×
“Moreover, telomere erosion and cellular senescence may be involved in cancer etiology and certain aging characteristics (Shay and Wright, 2001; Kim et al., 2002; Maser and Depinho, 2002).”
BackgroundTahara, H., Tokutake, Y., Maeda, S., Kataoka, H., Watanabe, T., Satoh, M., Matsumoto, T., Sugawara, M., Ide, T., Goto, M., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201377 · Cited by 130 · cited 1×
“Cells from WS patients have increased chromosomal aberrations (Fukuchi et al., 1989), telomere abnormalities (Schulz et al., 1996; Tahara et al., 1997), and dramatic premature replicative senescence (Martin et al., 1970).”
BackgroundOrren, D. K., Brosh, R. M., Nehlin, J. O., Machwe, A., Gray, M. D., & Bohr, V. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.17.3557 · Cited by 123 · cited 1×
“His-tagged wild-type and mutant WRN proteins were overexpressed and purified as described (Orren et al., 1999), except that 0.1% Nonidet P-40 (NP40) was included in all liquid chromatography buffers.”
MethodSelf-citationThe Werner syndrome helicase/exonuclease (WRN) disrupts and degrades D-loops in vitro
Orren, D. K., Theodore, S., & Machwe, A. (2002) · Biochemistry · doi:10.1021/bi0266986 · Cited by 112 · cited 4×
“Telomeric D-loop substrate was constructed by a two-step annealing process detailed previously (Orren et al., 2002).”
BackgroundMethodSelf-citationNew insights into the mechanism for clearance of apoptotic cells
Messmer, U. K., & Pfeilschifter, J. (2000) · BioEssays · doi:10.1002/1521-1878(200010)22:10<878::aid-bies2>3.0.co;2-j · Cited by 70
Machwe, A., Xiao, L., Theodore, S., & Orren, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108880200 · Cited by 35 · cited 2×
“The latter is not surprising, as WRN alone cannot unwind blunt-ended duplexes (Machwe et al., 2002) and has limited ability to unwind long duplexes (Brosh et al., 1999).”
BackgroundSelf-citation
Research works printed but not linked: 2
- Chakraverty RK and Hickson ID . (1999). Bioessays, 21, 286–294. · DOI · Paper page
- Oshima J . (2000). Bioessays, 22, 894–901. · DOI · Paper page
Cited by
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
“WRN interacts with TRF2 and can be detected at telomeres by ChIP and IF in S phase (Opresko et al. 2002, 2004; Crabbe et al. 2004; Machwe et al. 2004).”
Aubert, G., & Lansdorp, P. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00026.2007 · Cited by 1,188
DNA Repair, Genome Stability, and Aging
Lombard, D. B., Chua, K. F., Mostoslavsky, R., Franco, S., Gostissa, M., & Alt, F. W. (2005) · Cell · doi:10.1016/j.cell.2005.01.028 · Cited by 944
Human RecQ Helicases in DNA Repair, Recombination, and Replication
Croteau, D. L., Popuri, V., Opresko, P. L., & Bohr, V. A. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035428 · Cited by 538
“TRF2 stimulates (242) and POT1 inhibits the WRN exonuclease on substrates containing a telomeric ssDNA overhang (246).”
BackgroundKarlseder, J., Hoke, K., Mirzoeva, O. K., Bakkenist, C., Kastan, M. B., Petrini, J. H. J., & Lange, T. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020240 · Cited by 397
Metadata
- Authors
- Machwe, A., Xiao, L., & Orren, D. K.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Orren, David K
- Venue
- Oncogene
- Published
- 2004-01-08
- Volume
- 23
- Issue
- 1
- Pages
- 149-156
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1966888005
- Cited by
- 130
- References
- 31
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 5
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ellison Medical Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- TRF2, Werner syndrome, telomere maintenance, protein-protein interaction, premature senescence, genomic instability, premature aging, carcinogenesis
- MeSH terms
- Werner Syndrome Helicase, Base Sequence, DNA, DNA Helicases, Exodeoxyribonucleases, Exonucleases, Molecular Sequence Data, Werner Syndrome, Telomere, Telomeric Repeat Binding Protein 1, Telomeric Repeat Binding Protein 2, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.